Recombinant Staphylococcus aureus UPF0060 membrane protein SAOUHSC_02615 (SAOUHSC_02615)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Staphylococcus aureus UPF0060 Membrane Protein SAOUHSC_02615

The Recombinant Staphylococcus aureus UPF0060 membrane protein SAOUHSC_02615 is a protein of interest in microbiological research, particularly in the study of Staphylococcus aureus, a bacterium known for its pathogenicity and antibiotic resistance. This protein is part of the UPF0060 family, which is characterized by its conserved sequence across different species but lacks a well-defined function. The SAOUHSC_02615 protein is specifically identified in Staphylococcus aureus and has been recombinantly expressed for further study.

Characteristics of Recombinant SAOUHSC_02615 Protein

  • Expression and Source: The recombinant SAOUHSC_02615 protein is expressed in Escherichia coli (E. coli), a common host for recombinant protein production due to its well-understood genetics and ease of manipulation .

  • Protein Structure: The protein consists of 108 amino acids and is fused with an N-terminal His tag, facilitating purification and detection .

  • Purity and Storage: It is available as a lyophilized powder with a purity greater than 90% as determined by SDS-PAGE. Storage recommendations include maintaining it at -20°C or -80°C to prevent degradation .

Protein Structure and Function

Proteins' structures are crucial for their functions. The primary structure (sequence of amino acids) dictates the secondary, tertiary, and quaternary structures, which in turn determine the protein's function . For membrane proteins like SAOUHSC_02615, understanding these structures is essential for elucidating their roles in bacterial physiology and pathogenicity.

Future Directions

Further research on SAOUHSC_02615 should focus on its functional characterization, including its role in Staphylococcus aureus membrane stability, interaction with other proteins, and potential involvement in virulence mechanisms. This could involve biochemical assays, structural studies, and genetic manipulation to assess its impact on bacterial behavior.

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for guaranteed fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional charges apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type will be determined during the production process. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
SAOUHSC_02615; UPF0060 membrane protein SAOUHSC_02615
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-108
Protein Length
full length protein
Species
Staphylococcus aureus (strain NCTC 8325)
Target Names
SAOUHSC_02615
Target Protein Sequence
MLYPIFIFILAGLCEIGGGYLIWLWLREGQSSLVGLIGGAILMLYGVIATFQSFPSFGRV YAAYGGVFIIMSLIFAMVVDKQMPDKYDVIGAIICIVGVLVMLLPSRA
Uniprot No.

Target Background

Database Links
Protein Families
UPF0060 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the optimal expression system for recombinant SAOUHSC_02615 protein production?

For membrane proteins like SAOUHSC_02615, selection of an appropriate expression system is critical for maintaining native conformation and functional properties. While E. coli remains the most commonly used system due to its cost-effectiveness and rapid growth, membrane proteins often benefit from eukaryotic expression systems that provide appropriate post-translational modifications and membrane environments .

Comparative Expression System Outcomes for Membrane Proteins:

Expression SystemAdvantagesLimitationsYield Expectations
E. coliCost-effective, rapid growth, well-established protocolsLimited post-translational modifications, potential for inclusion bodies1-5 mg/L culture
Yeast (P. pastoris, S. cerevisiae)Eukaryotic folding machinery, moderate costLonger production time, different glycosylation patterns2-10 mg/L culture
Insect cellsMammalian-like glycosylation, suitable for complex proteinsHigher cost, longer production time5-20 mg/L culture
Mammalian cellsNative-like post-translational modificationsHighest cost, longest production time1-10 mg/L culture

For SAOUHSC_02615, an initial expression trial in multiple systems is recommended to determine optimal yield and functionality before scaling up production .

Which purification strategy provides the highest yield of functional SAOUHSC_02615?

Purification of membrane proteins like SAOUHSC_02615 requires careful consideration of detergent selection and chromatographic approaches. A multi-step purification protocol typically yields best results:

  • Affinity chromatography using an appropriate fusion tag (His-tag is commonly employed)

  • Size exclusion chromatography (SEC) to separate monomeric protein from aggregates

  • Ion exchange chromatography for further purification and removal of contaminants

For tag-free preparation, beginning with fusion tag expression followed by tag removal and subsequent hydrophobic interaction chromatography (HIC), SEC, or ion exchange chromatography (IEX) is recommended to ensure proper native folding .

How can we verify the structural integrity of purified recombinant SAOUHSC_02615?

Verification of structural integrity involves multiple analytical techniques:

  • SDS-PAGE and Western blotting for initial purity assessment and identity confirmation

  • Circular dichroism (CD) spectroscopy to analyze secondary structure content

  • Thermal shift assays to evaluate protein stability

  • Limited proteolysis to assess folding quality

  • Dynamic light scattering to determine homogeneity and detect aggregation

Functional assays specific to membrane proteins should also be employed to confirm biological activity, as structural integrity does not always guarantee functionality.

What role might SAOUHSC_02615 play in S. aureus membrane stability and pathogenicity?

Based on research on similar membrane proteins in S. aureus, particularly MspA (membrane stabilizing protein A), SAOUHSC_02615 may contribute to membrane integrity and function. Membrane proteins in S. aureus have been shown to affect multiple virulence-associated processes including:

  • Toxin production and secretion

  • Resistance to innate immune mechanisms

  • Iron homeostasis regulation

To investigate SAOUHSC_02615's specific role, researchers should consider the following experimental approaches:

  • Gene knockout studies comparing wild-type and SAOUHSC_02615-deficient strains

  • Complementation experiments to confirm phenotypic changes are specifically due to SAOUHSC_02615 loss

  • Proteomic analysis to identify interacting partners and affected pathways

  • Virulence assays in appropriate infection models

How do contradictory findings in the literature regarding SAOUHSC_02615 function affect research directions?

Resolving conflicting research findings requires systematic analysis of methodology and context. When evaluating contradictory claims about SAOUHSC_02615 function, researchers should:

  • Examine experimental conditions (culture medium, growth phase, strain differences)

  • Assess methodological differences (protein expression systems, purification protocols)

  • Consider genetic and environmental contexts that might influence protein function

  • Apply relationship categorization frameworks to understand the nature of contradictions

A useful approach is to organize contradictions into relationship types:

Contradiction TypeExampleResolution Strategy
Excitatory vs. InhibitorySAOUHSC_02615 enhances vs. inhibits toxin productionDetermine context-specific factors (strain differences, experimental conditions)
Positive vs. NegativeSAOUHSC_02615 is vs. is not essential for membrane stabilityExamine methodological differences and stringency of phenotypic assessment
Direct vs. IndirectSAOUHSC_02615 directly vs. indirectly affects pathogenicityPerform detailed mechanistic studies to establish causal pathways

This systematic approach helps identify whether contradictions represent genuine biological complexity or methodological discrepancies .

What mechanisms explain SAOUHSC_02615's potential contribution to functional membrane microdomains (FMMs)?

Membrane proteins like SAOUHSC_02615 may participate in the formation and stabilization of functional membrane microdomains similar to MspA. Potential mechanisms include:

  • Interaction with scaffold proteins like flotillin (FloA)

  • Association with carotenoid biosynthesis enzymes (e.g., CrtM) that contribute to membrane rigidity

  • Coordination with other membrane proteins to create specialized functional regions

To investigate these mechanisms, researchers should consider:

  • Co-immunoprecipitation studies to identify protein interactions

  • Lipidomic analysis to characterize membrane composition changes in SAOUHSC_02615 mutants

  • Fluorescence microscopy with appropriate membrane domain markers

  • Biophysical membrane characterization (fluidity, rigidity) in wild-type vs. mutant strains

What is the optimal experimental design to investigate SAOUHSC_02615's role in antibiotic resistance?

A robust experimental design should incorporate the five key steps of scientific investigation:

  • Define variables clearly:

    • Independent variable: SAOUHSC_02615 expression levels (wild-type, knockout, overexpression)

    • Dependent variable: Minimum inhibitory concentrations (MICs) for various antibiotic classes

    • Control variables: Growth conditions, strain background, cell density

  • Formulate specific, testable hypotheses:

    • H0: SAOUHSC_02615 expression level does not affect susceptibility to membrane-targeting antibiotics

    • H1: SAOUHSC_02615 expression level alters susceptibility to membrane-targeting antibiotics

  • Design treatments to manipulate the independent variable:

    • Wild-type S. aureus strain (baseline SAOUHSC_02615 expression)

    • SAOUHSC_02615 knockout strain (generated via allelic exchange)

    • Complemented knockout strain (for validation)

    • SAOUHSC_02615 overexpression strain

  • Determine experimental approach:

    • Between-subjects design comparing different strains

    • Within-subjects design testing multiple antibiotics on each strain

  • Plan measurement of dependent variables:

    • Standard MIC determination via broth microdilution

    • Time-kill assays for dynamic assessment

    • Membrane integrity assays following antibiotic exposure

This structured approach will provide strong evidence regarding SAOUHSC_02615's contribution to antibiotic resistance phenotypes.

How should researchers design experiments to differentiate between direct and indirect effects of SAOUHSC_02615 on virulence?

To distinguish direct from indirect effects, a multi-layered experimental approach is necessary:

  • Temporal analysis:

    • Monitor changes in gene expression and protein levels at various timepoints after SAOUHSC_02615 induction or repression

    • Early changes suggest direct regulation, while delayed effects indicate secondary consequences

  • Interaction studies:

    • Perform chromatin immunoprecipitation (ChIP) if SAOUHSC_02615 might have DNA-binding capability

    • Conduct protein-protein interaction studies using pull-down assays or bacterial two-hybrid systems

  • Pathway analysis:

    • Use RNA-seq to identify differentially expressed genes in wild-type vs. mutant strains

    • Apply pathway enrichment analysis to identify affected biological processes

  • Direct binding assays:

    • Purify recombinant SAOUHSC_02615 and test direct binding to suspected targets using surface plasmon resonance or microscale thermophoresis

  • In vivo validation:

    • Develop animal infection models comparing wild-type, knockout, and complemented strains

    • Measure multiple virulence endpoints (bacterial load, tissue damage, inflammatory markers)

What controls are essential when evaluating SAOUHSC_02615's interaction with other membrane components?

Proper controls are critical when studying membrane protein interactions:

Control TypePurposeImplementation
Empty vectorControls for effects of expression systemTransform with plasmid lacking SAOUHSC_02615 insert
Unrelated membrane proteinControls for general membrane perturbationExpress a membrane protein of similar size but unrelated function
Point mutantsIdentify critical functional residuesGenerate variants with mutations in predicted functional domains
Detergent-onlyControl for detergent effects in purificationProcess samples without protein through identical purification steps
Scrambled peptideFor interaction studiesUse randomized sequence of same amino acid composition
Biological replicatesAccount for biological variabilityPerform experiments with independently derived strains
Technical replicatesControl for measurement errorRepeat experiments multiple times under identical conditions

How should contradictory results regarding SAOUHSC_02615 function be reconciled in the literature?

When faced with contradictory findings about SAOUHSC_02615 function, researchers should:

  • Categorize contradictions systematically:

    • Excitatory vs. inhibitory relationships

    • Presence vs. absence of effects

    • Direct vs. indirect mechanisms

  • Examine experimental contexts:

    • Different S. aureus strain backgrounds (MRSA vs. MSSA, clinical vs. lab strains)

    • Growth conditions and media composition

    • Protein expression systems and tags used

  • Consider biological complexity:

    • SAOUHSC_02615 may have context-dependent functions

    • Post-translational modifications might alter activity

    • Interaction partners may differ between experimental systems

  • Apply meta-analysis techniques:

    • Quantitative assessment of effect sizes across studies

    • Evaluation of study quality and methodological rigor

    • Forest plots to visualize conflicting results and confidence intervals

This structured approach transforms apparent contradictions into opportunities for deeper understanding of the protein's complex biology.

What statistical approaches are most appropriate for analyzing SAOUHSC_02615 knockout phenotypes?

The choice of statistical analysis depends on the experimental design and data characteristics:

  • For comparing two groups (wild-type vs. knockout):

    • Student's t-test for normally distributed data

    • Mann-Whitney U test for non-parametric data

    • Consider paired tests if using matched samples

  • For multiple group comparisons:

    • One-way ANOVA followed by post-hoc tests (Tukey, Bonferroni) for normally distributed data

    • Kruskal-Wallis test followed by Dunn's test for non-parametric data

  • For time-course experiments:

    • Repeated measures ANOVA

    • Mixed-effects models to account for missing data points

  • For survival analysis:

    • Kaplan-Meier curves with log-rank test

    • Cox proportional hazards models for covariate adjustment

  • For complex datasets:

    • Principal component analysis for dimension reduction

    • Hierarchical clustering to identify patterns

    • Machine learning approaches for predictive modeling

Regardless of the test selected, researchers should:

  • Establish appropriate sample sizes through power analysis

  • Test assumptions of normality and homogeneity of variance

  • Control for multiple comparisons to avoid false positives

  • Report effect sizes alongside p-values

How can researchers integrate structural analysis with functional data to understand SAOUHSC_02615 mechanisms?

Integrating structural and functional data provides deeper mechanistic insights:

  • Structure prediction approaches:

    • Use homology modeling based on related membrane proteins

    • Apply ab initio modeling for unique domains

    • Employ molecular dynamics simulations to predict dynamic behavior

  • Structure-function correlation:

    • Generate point mutations in predicted functional domains

    • Perform alanine scanning of transmembrane regions

    • Create chimeric proteins with domains from related membrane proteins

  • Data integration strategies:

    • Map conservation scores onto structural models to identify critical regions

    • Visualize interaction sites based on co-immunoprecipitation data

    • Correlate membrane localization with functional outcomes

  • Computational analysis:

    • Apply molecular docking to predict ligand binding

    • Use electrostatic surface mapping to identify potential interaction interfaces

    • Perform evolutionary sequence analysis to identify co-evolving residues

  • Visualization techniques:

    • Create integrated visual models that overlay functional data on structural representations

    • Develop dynamic visualizations showing conformational changes and their functional consequences

By systematically connecting structural features to functional outcomes, researchers can develop testable hypotheses about the molecular mechanisms underlying SAOUHSC_02615's biological roles.

What strategies can overcome difficulties in membrane protein crystallization for SAOUHSC_02615?

Membrane protein crystallization presents significant challenges that can be addressed through multiple approaches:

  • Protein engineering strategies:

    • Truncation of disordered regions

    • Introduction of stabilizing mutations

    • Fusion with crystallization chaperones (e.g., T4 lysozyme)

    • Surface entropy reduction

  • Crystallization condition optimization:

    • Lipidic cubic phase crystallization

    • Bicelle crystallization methods

    • High-throughput screening of detergent/lipid combinations

    • Controlled dehydration techniques

  • Alternative structural determination methods:

    • Cryo-electron microscopy for larger complexes

    • Nuclear magnetic resonance for smaller membrane proteins or domains

    • Small-angle X-ray scattering for low-resolution envelope determination

  • Stabilization approaches:

    • Antibody fragment co-crystallization

    • Nanobody stabilization

    • Ligand-induced stabilization if binding partners are known

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.